Journal Home
Search for

Volume 86, Issue 3, Pages 219-224 (December 2009)


View previous. 10 of 21 View next.

Early insulin response and insulin sensitivity are equally important as predictors of glucose tolerance after correction for measurement errors

Lars BerglundabCorresponding Author Informationemail address, Christian Bernec, Kurt Svärdsuddd, Hans Garmob, Björn Zetheliusa

Received 11 August 2009; accepted 15 September 2009. published online 07 October 2009.

Abstract 

Aims

: We estimated measurement error (ME) corrected effects of insulin sensitivity (M/I), from euglycaemic insulin clamp, and insulin secretion, measured as early insulin response (EIR) from oral glucose tolerance test (OGTT), on fasting plasma glucose, HbA1c and type 2 diabetes longitudinally and cross-sectional.

Methods

: In a population-based study (n=1128 men) 17 men made replicate measurements to estimate ME at age 71 years. Effect of 1 SD decrease of predictors M/I and EIR on longitudinal response variables fasting plasma glucose (FPG) and HbA1c at follow-ups up to 11 years, were estimated using uncorrected and ME-corrected (with the regression calibration method) regression models.

Results

: Uncorrected effect on FPG at age 77 years was larger for M/I than for EIR (effect difference 0.10mmol/l, 95% CI 0.00;0.21), while ME-corrected effects were similar (0.02mmol/l, 95% CI −0.13;0.15mmol/l). EIR had greater ME-corrected impact than M/I on HbA1c at age 82 years (−0.11%, −0.28; −0.01%).

Conclusions

: Due to higher ME effect of EIR on glycaemia is underestimated as compared with M/I. By correcting for ME valid estimates of relative contributions of insulin secretion and insulin sensitivity on glycaemia are obtained.

a Department of Public Health/Geriatrics, Uppsala University, Uppsala, Sweden

b Uppsala Clinical Research Center, University Hospital, Uppsala, Sweden

c Department of Medical Sciences, Uppsala University, Uppsala, Sweden

d Department of Public Health/Family Medicine and Clinical Epidemiology, Uppsala University, Uppsala, Sweden

Corresponding Author InformationCorresponding author at: Uppsala Clinical Research Center, University Hospital, SE-751 85 Uppsala, Sweden. Tel.: +46 186119515; fax: +46 18506638.

PII: S0168-8227(09)00408-2

doi:10.1016/j.diabres.2009.09.016


View previous. 10 of 21 View next.